ES2087151T3 - Preparacion de composiciones complejas de liposomas y lipidos. - Google Patents

Preparacion de composiciones complejas de liposomas y lipidos.

Info

Publication number
ES2087151T3
ES2087151T3 ES90906530T ES90906530T ES2087151T3 ES 2087151 T3 ES2087151 T3 ES 2087151T3 ES 90906530 T ES90906530 T ES 90906530T ES 90906530 T ES90906530 T ES 90906530T ES 2087151 T3 ES2087151 T3 ES 2087151T3
Authority
ES
Spain
Prior art keywords
compounds
liposome
aprotic solvent
lipids
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906530T
Other languages
English (en)
Inventor
Francis C Szoka Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of ES2087151T3 publication Critical patent/ES2087151T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

FORMULACIONES DE COMPUESTOS DE PARTICULAS LIPIDICAS Y LIPOSOMAS SE PREPARAN DISOLVIENDO EN UNA SOLUCION DE LIPIDOS FORMADORES DE LIPOSOMAS EN UN SOLVENTE APROTICO COMO EL DMSO, QUE CONTIENE OPCIONALMENTE UNA CANTIDAD SOLUBILIZABLE EN LIPIDOS DE UN ALCANOL INFERIOR, E INYECTANDO LA SOLUCION RESULTANTE EN UNA SOLUCION ACUOSA. LA SUSPENSION DE PARTICULA LIPIDICA O DE LIPOSOMAS RESULTANTE PUEDE ENTONCES DIALIZARSE O BIEN CONCENTRARSE. ESTE METODO ES ESPECIALMENTE UTIL PARA COMPUESTOS QUE SON POCO SOLUBLES EN SOLUCION ACUOSA, PERO ES GENERALMENTE UTIL PARA CUALQUIER COMPUESTO O COMBINACION DE COMPUESTOS QUE PUEDEN DISOLVERSE EN EL SOLVENTE APROTICO O LA MEZCLA DE SOLVENTE APROTICO/ALCANOL INFERIOR.
ES90906530T 1989-03-31 1990-03-28 Preparacion de composiciones complejas de liposomas y lipidos. Expired - Lifetime ES2087151T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05

Publications (1)

Publication Number Publication Date
ES2087151T3 true ES2087151T3 (es) 1996-07-16

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906530T Expired - Lifetime ES2087151T3 (es) 1989-03-31 1990-03-28 Preparacion de composiciones complejas de liposomas y lipidos.

Country Status (12)

Country Link
EP (1) EP0467954B1 (es)
JP (1) JP2798302B2 (es)
AT (1) ATE137403T1 (es)
AU (1) AU638245B2 (es)
CA (1) CA2050679C (es)
DE (1) DE69026820T2 (es)
DK (1) DK0467954T3 (es)
ES (1) ES2087151T3 (es)
HK (1) HK1000912A1 (es)
HU (1) HU208070B (es)
NO (1) NO303205B1 (es)
WO (1) WO1990011780A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
JP3479535B2 (ja) 1993-07-08 2003-12-15 ザ リポソーム カンパニー、インコーポレーテッド リポソームの粒径を制御する方法
WO1995008918A1 (en) * 1993-09-29 1995-04-06 Gist-Brocades N.V. A novel antifungal composition
CA2223179A1 (en) * 1995-06-07 1996-12-19 Bob Dale Brown Phosphonic acid-based cationic lipids
DE69924004T2 (de) * 1998-12-22 2006-02-09 United States Of America Represented By The Secretary, Department Of Health & Human Services Verabreichungssystem für wasserunlösliche arzneistoffe
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
US7572833B2 (en) 2000-10-26 2009-08-11 Senju Pharmaceutical Co., Ltd. Drug composition comprising dipeptidyl aldehyde derivative
AU1999802A (en) * 2000-12-01 2002-06-11 Lawrence Boni Preparation of large liposomes by infusion into peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
WO2008114274A1 (en) * 2007-03-19 2008-09-25 Fresenius Kabi Onclology Ltd. Proliposomal and liposomal compositions
RU2010123882A (ru) * 2007-11-14 2011-12-20 Те Риджентс Оф Те Юниверсити Оф Калифорния (Us) Модифицированные стеринами амфифильные липиды
HUE052571T2 (hu) * 2008-09-27 2021-05-28 Jina Pharmaceuticals Inc Lipid alapú gyógyszerészeti készítmények helyi alkalmazáshoz
JP6051157B2 (ja) 2010-07-14 2016-12-27 中国医学科学院▲薬▼物研究所 一種インスリンの脂質複合物及び作製方法や製剤
EP3177269A4 (en) * 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into lipid vesicles
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関 則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
NO303205B1 (no) 1998-06-15
EP0467954A4 (en) 1992-06-03
EP0467954B1 (en) 1996-05-01
HU903559D0 (en) 1991-12-30
DE69026820D1 (de) 1996-06-05
JP2798302B2 (ja) 1998-09-17
HU208070B (en) 1993-08-30
EP0467954A1 (en) 1992-01-29
AU638245B2 (en) 1993-06-24
DE69026820T2 (de) 1996-11-28
CA2050679C (en) 1998-09-22
DK0467954T3 (da) 1996-05-28
JPH04506207A (ja) 1992-10-29
NO913816D0 (no) 1991-09-27
NO913816L (no) 1991-11-26
CA2050679A1 (en) 1990-10-01
HK1000912A1 (en) 1998-05-08
ATE137403T1 (de) 1996-05-15
AU5434590A (en) 1990-11-05
WO1990011780A1 (en) 1990-10-18
HUT59818A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
ES2087151T3 (es) Preparacion de composiciones complejas de liposomas y lipidos.
CA1262093C (en) STEROID LIPOSOMES
DE3867866D1 (de) Liposomzubereitung und ihre herstellung.
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
IE780464L (en) Liposome compositions
EA200000765A1 (ru) Получение липидной смеси и фосфолипидная суспензия, содержащая липидную смесь
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
ES2074878T3 (es) Polvo preliposomal de polieno liposomal y metodo para su preparacion.
RU2000124317A (ru) Эритропоэтиновая липосомальная дисперсия
NO174833C (no) Fremgangsmåte for fremstilling av et injiserbart preparat
ES8801085A1 (es) Un metodo para preparar una crema antifungica
EA199800745A1 (ru) Устовершенствования в области контрастных агентов
CO4480019A1 (es) Liposomas de cetoprofeno
DE69738416T2 (de) Liposomale zubereitungen von indolocarbazol-derivaten
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
FI103178B (fi) Menetelmä vaikuttavaa ainetta sisältävien vesipohjaisten liposomisuspe nsioiden valmistamiseksi
JPS5675438A (en) Method for stabilizing aqueous solution of cyanocobalamin
ATE112679T1 (de) Wässrige bereitung von liposomenzusammensetzungen.
DE3764843D1 (de) Hochresorbierbare zubereitungsform des hymecromons und verfahren zur herstellung derselben.
ATE270093T1 (de) Schaumförmige zubereitungen mit einem gehalt an grenzflächenaktiven substanzen und elektrolyten
FR2523966B1 (fr) Derives de pyridine et de pyrazine, leur preparation et leur application en tant qu'agents fongicides
JPS6431720A (en) Antihyperlipemic agent consisting of pyrimido(2,1-b)benzothiazole derivative
KR970042995A (ko) 크산틴 유도체와 리포조옴과의 복합체를 함유하는 피부 침투성이 개선된 인체 세정체 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0467954

Country of ref document: ES